| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/17/2002 | EP1196180A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 04/17/2002 | EP1196169A1 Compounds having cytokine inhibitory activity |
| 04/17/2002 | EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same |
| 04/17/2002 | EP1196159A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/17/2002 | EP1196141A1 Use of at least one extract of a plant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 04/17/2002 | EP1196129A1 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 04/17/2002 | EP1112079B1 Myrtle extract, preparation method and use |
| 04/17/2002 | EP0948313B1 Use of an extract of gaboon resin in cosmetics and pharmaceutics, in particular for dermatological purposes |
| 04/17/2002 | EP0937038B1 Vitamin d analogues |
| 04/17/2002 | EP0915702B1 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 04/17/2002 | EP0901378B1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
| 04/17/2002 | EP0662827B1 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/17/2002 | CN1345317A (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 04/17/2002 | CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis |
| 04/17/2002 | CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1345247A Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas |
| 04/17/2002 | CN1345244A Herbal compositions and uses for treatment tof allergic reactions |
| 04/17/2002 | CN1345243A Drugs, foods, drinks and feeds containing cocoa component |
| 04/17/2002 | CN1345228A Dermatological topical composition |
| 04/17/2002 | CN1345224A Composition for cosmetic and dermatological skin care |
| 04/17/2002 | CN1344709A Novel di-quaternary ammonium salt compound |
| 04/17/2002 | CN1344552A Chinese medicine beautifying pellet and its compounding process |
| 04/17/2002 | CN1344550A Beriberi treating Jiaoyuxiang ointment prepared with Chinese and Western medicine material |
| 04/17/2002 | CN1344546A Kebai Tincture and its prepn and application |
| 04/17/2002 | CN1344544A Specific burn-treating Chinese medicine prepn. |
| 04/17/2002 | CN1082822C Cosmetic and skin-useful composition containing water from hot spring or mineral water and agent against acne and oldening |
| 04/17/2002 | CN1082809C 肥皂组合物 Soap compositions |
| 04/16/2002 | US6372802 Aniline disulfide derivatives for treating allergic diseases |
| 04/16/2002 | US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | US6372756 Narcotics or analgesics |
| 04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
| 04/16/2002 | US6372731 Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
| 04/16/2002 | US6372202 Cosmetic composition, in particular a make-up composition, comprising a pigment derived from pyrrolopyrrole |
| 04/16/2002 | US6372197 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029044A2 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002028905A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028904A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | WO2002028860A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | WO2002028853A1 Benzylamine compound, process for producing the same, and intermediate therefor |
| 04/11/2002 | WO2002028842A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist |
| 04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
| 04/11/2002 | WO2002028481A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | WO2002028480A2 Methods of therapy for b-cell malignancies |
| 04/11/2002 | WO2002028435A1 Pharmaceutical vehicle |
| 04/11/2002 | WO2002028434A2 Use of a ppar delta activator for treating inflammatory conditions |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028420A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | WO2002028390A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 04/11/2002 | WO2002028359A2 Concordantly uv-photoprotecting and artificial tanning compositions |
| 04/11/2002 | WO2002028355A2 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002004531A3 Process for preparing benzoxazin-4-one polymer conjugates |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | WO2001085128A3 Skin protectant spray compositions |
| 04/11/2002 | WO2001083450A3 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/11/2002 | WO2001083031A3 Topical composition for the treatment of psoriasis and related skin disorders |
| 04/11/2002 | WO2001080920A3 Antimicrobial bioabsorbable materials |
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | WO2001074307A3 Compositions and methods for treating hair loss using oximyl- and hydroxylamino- prostaglandins |
| 04/11/2002 | WO2001045648A3 Use of a vaccinium-type extract as an anti-glycation agent |
| 04/11/2002 | WO2001036374A3 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 04/11/2002 | WO2001028589A3 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 04/11/2002 | WO2000032181A9 Method for reducing free-radical induced injury |
| 04/11/2002 | US20020042513 Therapeutic compounds |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
| 04/11/2002 | US20020042442 Ureas and carbamates of N-Heterocyclic carboxylic acids and carboxylic acid isosteres |
| 04/11/2002 | US20020042441 N-substituted indoles useful in the treatment of diabetes |
| 04/11/2002 | US20020042438 Use of ergothioneine and/or its derivatives as an anti-glycation agent |
| 04/11/2002 | US20020042435 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/11/2002 | US20020042433 For promoting animal growth and improving feed utilization efficiency by an animal, and as antimicrobial component in animal feeds |
| 04/11/2002 | US20020042427 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 04/11/2002 | US20020042421 Antiinflammatory agents |
| 04/11/2002 | US20020042416 6-azauracil derivatives as IL-5 inhibitors |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042401 Use of sex steroids function modulators to treat wounds and fibrotic disorders |
| 04/11/2002 | US20020042399 Analgesics; skin disorders |
| 04/11/2002 | US20020042380 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042373 Administering thrombin receptor antagonist; bone disorders |